Skip to main content
SpringerLink
Log in

Thrombolytic therapy in myocardial infarction: Are fibrinolytic drugs comparable, and similarly effective?

  • Chapter
Improvement of Myocardial Perfusion

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 50))

  • 46 Accesses

Abstract

Many authors consider that SK and UK are both useful thrombolytic agents [1]. They also consider that the choice between SK and UK is influenced by economic considerations [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sharma GVRK, Cella G, Parisi AF, Sasahara AA (1982) Thrombolytic therapy. N. Engl. J. Med. 306: 1268–1276

    Google Scholar 

  2. Laffel GL, Braunwald E (1984) Thrombolytic therapy: a new strategy for the treatment of acute myocardial infarction (first of two parts). N. Engl. J. Med. 311: 710–717

    Article  PubMed  CAS  Google Scholar 

  3. Samama M, Szwarcer E, Conard J, Horellou MH (1984) Thrombolysis. In: Recent advances in blood coagulation; n° 4, L. Poller (ed) Churchill Livingstone, pp 267–299

    Google Scholar 

  4. Robbins KC (1982) Fibrinolysis. In: Kwaan HC, Bowie EJW (ed) Thrombosis. W.B. Sanders Company, Philadelphia pp 23–28

    Google Scholar 

  5. de Prost D, Guerot C, Laffay N, Horellou MH, Samama M (1983) Intra coronary thrombolysis with streptokinase or lys-plasminogen/urokinase in acute myocardial infarction: effects on re-canalization and blood fibrinolysis. Thromb. haemostas. 50: 792–796

    Google Scholar 

  6. Tennant SN, Dixon J, Venable JC, Page HL, Roach A, Kaiser AB et al. (1984) Intra coronary thrombolysis in patients with acute myocardial infarction: comparison of the efficacy of urokinase With streptokinase. Circulation 69: 756–760

    Article  PubMed  CAS  Google Scholar 

  7. Conard J, Samama M (1972) Laboratory control of SK therapy in Losito R. Ed. Present status of thrombosis its pathophysiology, diagnosis and treatment. Proceedings of International Symposium on intravascular coagulation and fibrinolysis. Sherbrooke Schattauer — Verlag, Stuttgart pp 191–198

    Google Scholar 

  8. Marder VJ (1979) Use of thrombolytic agents choice of patient, drug, administration, laboratory monitoring. Annals Intern Med 90: 802–808

    CAS  Google Scholar 

  9. Samama M, Conard J (1977) Biological results during UK therapy at different doses. In Paoletti R., Sherry S. (eds) Thrombosis and Urokinase. Academic Press, New York, 1977, 243–244

    Google Scholar 

  10. Conard J, Samama M, Milochevitch R, Horellou MH, Chabrun B, Prestat J (1979) Complicactions hémorragiques au cours de 98 traitements par la SK. Place de la surveillance biologique. Nouv Presse Méd 8: 1319–1325

    PubMed  CAS  Google Scholar 

  11. Timmis GP, Bandagharan V, Ramos RG (1984) Hemorrhage and the products of fibrinogen digestion after intra-coronary administration of streptokinase. Circulation 69: 1146–1152

    Article  PubMed  CAS  Google Scholar 

  12. Gold HK, Leinbac RC, Palacios IF (1983) Coronary reocclusion after selective administration of streptokinase. Circulation 68: 150–154

    Google Scholar 

  13. Lee G, Low RI, Takeda P (1982) Importance of follow-up medical and surgical approaches to prevent reinfaction, reocclusion, and recurrent angina following intracoronary thrombolysis with streptokinase in acute myocardial infarction. Am Heart J 104: 921–924

    Article  PubMed  CAS  Google Scholar 

  14. Serradimigni A, Romani A, Chiche B, Aubry J, Philip F (1981) Les indications des thrombolytiques dans les thromboses veineuses et l’embolie pulmonaire. Rev. Prat. 31: 3793–3804

    PubMed  CAS  Google Scholar 

  15. Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, Ward CA, Bennett WF, Yelverton E, Seeburg PH, Heyneker HL, Goeddel DV, Collen D (1983) Cloning and expression of human tissue-type plasminogen activator cDNA in E. Coli. Nature 301: 214–220

    CAS  Google Scholar 

  16. Zamarron C, Lijnen HR, Van Hoef B, Collen D (1984) Biological and thrombolytic properties of proenzyme and active forms of human urokinase. I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology. Thromb. Haemostas. 52: 19–23

    CAS  Google Scholar 

  17. Sobel BE, Gross RW, Robison AK (1984) Thrombolysis, clot selectivity and kinetics. Circulation 70: 160–164

    Article  PubMed  CAS  Google Scholar 

  18. Sobel BE, Geltman EM, Tiefenbrunn AJ (1984) Improvement of regional myocardial metabolism after coronary thrombosis induced with tissue type plasminogen activator or streptokinase. Circulation 69: 983–990

    Article  PubMed  CAS  Google Scholar 

  19. Matsuo O, Rijnen DC, Collen D (1981) Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Thromb. Haemostas. 45: 225–229

    CAS  Google Scholar 

  20. Smith RAG, Dupe RJ, English PD, Green J (1981) Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy. Nature, 290: 505–508

    Article  PubMed  CAS  Google Scholar 

  21. Gurewich V, Parnell R, Louie S, Kelley P, Suddith RL, Greenlee R (1984) Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). J. Clin. Invest. 73: 1731–1739

    Article  PubMed  CAS  Google Scholar 

  22. Kasper W, Erbel R, Meinertz T (1984) Intracoronary thrombolytis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction. J. Am. Cardiol. 4: 357–363

    Article  CAS  Google Scholar 

Download references

Authors
  1. M. Samama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Szwarcer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Internal Medicine II, Johannes Gutenberg University, Mainz, Federal Republic of Germany

    Jürgen Meyer MD , Raimund Erbel MD  & Hans Jürgen Rupprecht MD ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Martinus Nijhoff Publishers, Dordrecht

About this chapter

Cite this chapter

Samama, M., Szwarcer, E. (1985). Thrombolytic therapy in myocardial infarction: Are fibrinolytic drugs comparable, and similarly effective?. In: Meyer, J., Erbel, R., Rupprecht, H.J. (eds) Improvement of Myocardial Perfusion. Developments in Cardiovascular Medicine, vol 50. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-5032-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-5032-0_8

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8729-2

  • Online ISBN: 978-94-009-5032-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation